OKYO Pharma Ltd. Form 6-K Summary
Reporting date: July 27, 2023. This Form 6-K was furnished by OKYO Pharma Ltd., a foreign private issuer that files annual reports on Form 20-F.
Business Context and Period
The filing reports a corporate leadership appointment and does not provide operating or financial results for a specified reporting period.
Key Financial Metrics
- Revenue, profit, cash flow, margins, debt, liquidity, and other financial metrics: the filing text does not provide clear values.
Material Changes
- OKYO appointed William A. Clementi, Pharm.D., FCP as Chief Operating Officer.
Outlook, Risks, and Unusual Items
The filing contains no guidance, outlook, management discussion of financial performance, risk update, contingency, or unusual financial item. The appointment announcement is furnished as Exhibit 99.1 and is not deemed filed for purposes of Section 18 of the Securities Exchange Act, nor incorporated by reference into other filings unless expressly stated.
Investor Verification Points
- Verify the responsibilities, effective date, and terms of William A. Clementi’s appointment as Chief Operating Officer.
- Review Exhibit 99.1 for additional biographical or organizational details.
- Consult the company’s latest Form 20-F or other financial filing for financial condition, liquidity, cash runway, and operating results.